a5 laboratories inc (AFLB:OTC US)
a5 laboratories inc (AFLB) Snapshot
|
Open
$0.0040
|
Previous Close
$0.0040
|
|
|
Day High
$0.0049
|
Day Low
$0.0040
|
|
|
52 Week High
02/19/13 - $0.05
|
52 Week Low
08/16/12 - $0.0020
|
|
|
Market Cap
232.7K
|
Average Volume 10 Days
539.7K
|
|
|
EPS TTM
$-0.02
|
Shares Outstanding
58.2M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
a5 laboratories inc (AFLB) Related Businessweek News
No Related Businessweek News Founda5 laboratories inc (AFLB) Details
A5 Laboratories, Inc., a development stage company, intends to provide contract research and laboratory services in North America. The company specializes in the production of natural interferons using its gamma interferon production technology that allows producing interferons for the human and animal health market. It plans to provide a range of analytical services to support a client’s quality control, product development, method development, validation, and marketed product activities; consulting and analytical services in chemistry, microbiology, and chromatography; and quality assurance and support services. The company was formerly known as El Palenque Vivero, Inc. and changed its name to A5 Laboratories, Inc. in March 2010. A5 Laboratories, Inc. was founded in 2006 and is based in Baie-D'Urfé, Canada.
a5 laboratories inc (AFLB) Top Compensated Officers
a5 laboratories inc (AFLB) Key Developments
A5 Laboratories Inc. announced the appointment of Mr. Frank Neukomm, current Chairman of American Security Resources Corporation as Chairman and CEO. Mr. Robert Farr appointed as COO and President.
On May 10, 2012, the board of directors of A5 Laboratories Inc. dismissed Berman & Company, P.A, as the company’s independent registered public accounting firm. On May 10, 2012, the company’s board of directors approved the engagement of Bravos & Associates, Certified Public Accountants, LLC, as the company’s new independent registered public accounting firm.
On 05/16/2012, A5 Laboratories Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
| Recently Viewed | |||
| AFLB:US | $0.00 USD | 0.00 |  |
| Company | Last | Change | |
| No competitor information is available for AFLB. | |||
| View Industry Companies | |||
Industry Analysis
AFLB
Industry Average
| Valuation | AFLB | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | -- | Not Meaningful |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact A5 LABORATORIES INC, please visit www.a5labs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
